Surgical site infection (SSI) is a well-characterized morbidity after vascular surgical procedures, especially after infrainguinal and lower extremity bypass. Rates of SSI after these interventions range from 4.8% to 38.5%, which is higher than predicted for “clean” (type I/II) wounds (2%-6%). SSI rates are increased because of the proximity of wounds to the perineum and genitalia, use of prosthetic materials, and disruption of lymphatic vessels during groin incisions; most are attributable to inoculation by skin flora or direct bacterial
spread at the time of initial operation.



